Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2008-04-01
2008-04-01
Rawlings, Stephen L. (Department: 1643)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023500, C530S350000
Reexamination Certificate
active
09581651
ABSTRACT:
A recombinant polynucleotide encoding migrating stimulating factor (MSF) or variants or fragments or derivatives or fusions thereof or fusions of said variants or fragments or derivatives. Reagents are disclosed which can distinguish MSF and fibronectin, and which can distinguish polynucleotides which encode MSF or fibronectin. These reagents are believed to be useful in, for example, diagnosing cancer. MSF or variants or fragments or derivatives or fusions thereof, or fusions of said variants or fusions or derivatives, are useful in modulating cell migration and in wound healing.
REFERENCES:
patent: 4980279 (1990-12-01), Peters et al.
patent: 5049658 (1991-09-01), Kimizuka et al.
patent: 5124155 (1992-06-01), Reich
patent: 5300630 (1994-04-01), Matsuura et al.
patent: 5571679 (1996-11-01), Sekiguchi et al.
patent: 5629291 (1997-05-01), Ruoslahti et al.
patent: 5830700 (1998-11-01), Irani
patent: 0 207 751 (1986-06-01), None
patent: 0 344 134 (1989-05-01), None
patent: WO 90/00567 (1990-01-01), None
patent: WO 94/16085 (1994-07-01), None
patent: WO 99/02674 (1999-01-01), None
patent: WO 99/31233 (1999-06-01), None
Schor SL, et al. Cancer Res. Dec. 2003; 63 (24): 8827-36.
Bendig MM. Genet Eng. 1988; (7): 91-127.
Bristow AF. Trends Biotechnol. Jul. 1993; 11 (7): 301-5.
Benoliel AM, et al. J Cell Sci. Sep. 1997; 110 (Pt 17): 2089-97.
Skolnick J, et al. Trends Biotechnol Jan. 2000; 18 (1): 34-9.
Lazar E, et al. Mol Cell Biol Mar. 1988; 8 (3): 1247-52.
Burgess WH, et al. J Cell Biol Nov. 1990; 111 (5 Pt 1): 2129-38.
Gura T. Science. Nov. 7, 1997; 278 (5340): 1041-2.
Ward AM. Developmental Oncol. 1985; 21: 91-106.
Houdebine LM. J Biotechnol. May 31, 1994; 34 (3): 269-87.
Verma IM, et al. Nature. Sep. 18, 1997; 389 (6648): 239-42.
Patterson AP. Memorandum (Jan. 14, 2003); pp. 3.
Pandha HS, et al. Cur Opin Invest Drugs. 2000; 1 (1): 122-34.
Amalfitano A, et al. Cur Gene Ther. 2002; 2: 111-33.
Schor et al. (Breast Cancer Res. 2001; 3: 373-379).
Takada et al. (Mol. Endocrinol. 2000; 14 (5): 733-740).
Guo et al. (Proc. Natl. Acad. Sci. USA. Jun. 22, 2004; 101 (25): 9205-9210).
GENBANK Accession No. AJ276395 [gi: 12053816].
UniProtKB Entry No. P02751 (25 pages).
Kornblihtt, et al., Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene, EMBO Sequence Database Accession No. X0271; 4:1755-1759(1985).
Kornblihtt et al., Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene, EMBO, (USA) vol. 4 pp. 1755-1759 (1985).
Kornblihtt et al., SWISSPROT Sequence Database Accession No. P02751, (1986).
PIRI Sequence database (1985) Accession Ref. FNHU.
Dean et al., Cloning and analysis of the promoter region of the human fibronectin gene; Proc. Nat;. Acad. Sci, USA, vol. 84, pp. 1876-1880, Apr. 1987.
Hynes et al., EMBL Data library PIR2 AccessionNo. S14428, 1989.
Desimone et al., Identification and characterization of alternatively spliced fibronectin mRNAs expressed in early Xenopus embroys, SWISSPROT Database Accession Ref. FINC—XENLA, Dev. Biol. vol. 149 pp. 357-369 (1992).
Schor, Fibroblast subpopulations as accelerators of tumor progression: The role of migration stimulating factor, Epithelial-Mesenchymal Interactions in Cancer, 1995 pp. 273-296, Switzerland.
Schor et al., Migration stimulating factor (MSF): Its structure mode of action and possible function in health and disease; The Society of Experimental Biology 1993, pp. 235-251, UK.
Grey et al., Purification of the migration stimulating factor produced by fetal and brest cancer patients fibroblasts, Proc. Natl. Acad. Sci, USA, vol. 86, pp. 2438-2422, Apr. 1989.
Schor et al., Fetal-like fibroblasts: their production of migration stimulating factor and role in tumor progression, Mammary Tumorigenesis and Malignant Progression, pp. 277-298, 1994.
Irwin et al., Inter-and intra-site hetrogeneity in the expression of fetal-like phenotypic characteristic by gingival fibroblasts: potential significance for wound healing, Journal of Cell Science, vol. 107, p. 1333-1346 (1994) UK.
Schor et al., Phenotypic heterogeneity in breast fibroblasts: Functional anomaly in fibroblasts from histologically normal tissue adjacent to carcinoma, Int. J. Cancer, vol. 59, pp. 25-32 (1994).
Picardo et al., Migration stimulating activity in serum of breast cancer patients, The Lancet, vol. 337, pp. 130-134, Jan. 19, 1991.
Ellis et al., Antogonistic effects of TGF-β1 and MSF on fibroblast migration and hyaluronic acid synthesis, Possible implications for dermal wound healing, Journal of Cell Science, vol. 102, pp. 447-456 (1992) UK.
Picardo et al., Detection of migration stimulating actvity in wound fluid, Experimental and Molecular Pathology vol. 57, pp. 8-21 (1992).
Schor et al., Heterogeneity amoungst fibroblasats in the production of migration stimulating factor (MSF): Implications for cancer pathogenesis, Cell Motility Factors, pp. 127-146, 1992.
Schor et al., Fibroblasts from cancer patients display a mixture of both feotal and adult-like phenotypic characteristics; Journal of Cell Science, vol. 90, pp. 401-407 (1988) UK.
Schor et al., Feotal and cancer patient fibroblasts produce an autocrine migration stimulating factor not made by normal adult cells, Journal of Cell Science, vol. 90, pp. 391-399 (1988) UK.
Schor et al., Characterizationof migration-stimulating factor (MSF): Evidence of it role in cancer pathogenesis, Cancre Investigation vol. 8(6), pp. 665-667, (1990).
Schor et al., Mechanism of action of the migration stimulating factor produced by fetal and cancer patient fibroblasts: Effect on hyaluronic acid synthesis, In Vitro Cellular Development and Biology, vol. 25, No. 8, pp. 737-746, Aug. 1989.
Schor Ana Maria
Schor Seth Lawrence
Knobbe Martens Olson & Bear LLP
Rawlings Stephen L.
University of Dundee
LandOfFree
Polypeptides, polynucleotides and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polypeptides, polynucleotides and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptides, polynucleotides and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3949520